SMARCB1 and neoplasm: The constellation of findings in tumor and peripheral blood sequencing suggested the possibility of germline single copy <i>SMARCB1</i> loss, followed by somatic loss of the remaining <i>SMARCB1</i> allele due to copy neutral loss-of-heterozygosity.